These final results, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the strategy of targeting ACKR3 as a unique way to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Conditions. Investigate on conolidine is limited, https://conolidineisnotanopioid65319.tribunablog.com/top-latest-five-conolidine-urban-news-41220342